chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Nausea
Clinical narrative: Pt has a history of CAD (status post multiple stents) and non-insulin dependent DM Type 2. Pt presented with 3 days of chest pain, shortness of breath, generalized malaise, and intermittent nausea. Pt states that she has had close contact with several family members with acute COVID infection. She was admitted due to acute hypoxic respiratory failure secondary to COVID-19 pneumonia.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Hypoxia, Inappropriate schedule of product administration
Clinical narrative: The patient was on hospice with Hospice care for Cirrhosis of the Liver.  The patient tested positive for Covid/-19 on 08/12/2021 at Healthcare and was diagnosed with Covid PNA and hypoxia.  The patient was transferred to Hospice care.  The patient expired on 8/18/2021.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: The patient was on hospice with Hospice care for Cirrhosis of the Liver.  The patient tested positive for Covid/-19 on 08/12/2021 at Healthcare and was diagnosed with Covid PNA and hypoxia.  The patient was transferred to Hospice care.  The patient expired on 8/18/2021.
Age: 21.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received high dose fluzone even though she is under 65.  At this time she does not have any side effects
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy site unspecified normal, Blood test normal, Postmenopausal haemorrhage, Smear cervix normal, Ultrasound scan normal
Clinical narrative: Postmenopausal bleeding.  Period started on 5/17/21, again on 6/13/21, again on 8/18/21 and again on 9/21/22.  I have been in menopause for 13 years with no periods.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atelectasis, Atrial fibrillation, Atrial flutter, Bradycardia
Clinical narrative: 4/6/2022-Presents to ED c/o AMS. Report of unwitnessed fall 2 days ago, no medical care. Covid + test. Ct head-no acute intracranial hemorrhage. Ct chest-mild bibasilar atelectasis. Admit AMS and PNA. B/P 170-190/100's. Started ceftriaxone and doxy. O2 sat 90's on RA. WBC's WNL.  4/7/2022-EEG -general slowing and no epileptiform discharges. Temp-100.1 continue antibiotics. Latest BP-128-84. 4/9/2022-New onset AFib with flutter-Cardizem BID ordered, continue Toprol and start Eliquis. Eco-EF55-60% otherwise unremarkable.  4/10/2022-Tele NSR 70-80's 4/11/2022-Continue doxy & ceftriaxone on RA.  4/17/2022-HR-40-50's MD aware, map>65, spo2 90's RA.  4/18/2022- Rapid called, no responding to verbal stimuli, brady 4/18/2022- 52 and hypotensive 91/60. Bolus and atropine given improvement of HR to 85. Now on 2L 02 via NRB 02 sat was 86% now 100%. Placed on 2L NC. Finished ceftriaxone and doxy.  4/19/2022-Has intermittent delirium, with baseline HX of TBI/dementia. VSS.  4/20/2022-On RA now. 4/22/2022-VSS  97/65 HR 64  4/25/2022-BP-93/59 and HR 73. Spo2 97% on RA.  4/27/2022-Was awaiting local care placement received Covid -test.  4/28/2022- VSS, discharge to local care.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram head normal, Computerised tomogram thorax abnormal, Delirium, Echocardiogram normal
Clinical narrative: 4/6/2022-Presents to ED c/o AMS. Report of unwitnessed fall 2 days ago, no medical care. Covid + test. Ct head-no acute intracranial hemorrhage. Ct chest-mild bibasilar atelectasis. Admit AMS and PNA. B/P 170-190/100's. Started ceftriaxone and doxy. O2 sat 90's on RA. WBC's WNL.  4/7/2022-EEG -general slowing and no epileptiform discharges. Temp-100.1 continue antibiotics. Latest BP-128-84. 4/9/2022-New onset AFib with flutter-Cardizem BID ordered, continue Toprol and start Eliquis. Eco-EF55-60% otherwise unremarkable.  4/10/2022-Tele NSR 70-80's 4/11/2022-Continue doxy & ceftriaxone on RA.  4/17/2022-HR-40-50's MD aware, map>65, spo2 90's RA.  4/18/2022- Rapid called, no responding to verbal stimuli, brady 4/18/2022- 52 and hypotensive 91/60. Bolus and atropine given improvement of HR to 85. Now on 2L 02 via NRB 02 sat was 86% now 100%. Placed on 2L NC. Finished ceftriaxone and doxy.  4/19/2022-Has intermittent delirium, with baseline HX of TBI/dementia. VSS.  4/20/2022-On RA now. 4/22/2022-VSS  97/65 HR 64  4/25/2022-BP-93/59 and HR 73. Spo2 97% on RA.  4/27/2022-Was awaiting local care placement received Covid -test.  4/28/2022- VSS, discharge to local care.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction normal, Electroencephalogram normal, Fall, Hypotension, Mental status changes
Clinical narrative: 4/6/2022-Presents to ED c/o AMS. Report of unwitnessed fall 2 days ago, no medical care. Covid + test. Ct head-no acute intracranial hemorrhage. Ct chest-mild bibasilar atelectasis. Admit AMS and PNA. B/P 170-190/100's. Started ceftriaxone and doxy. O2 sat 90's on RA. WBC's WNL.  4/7/2022-EEG -general slowing and no epileptiform discharges. Temp-100.1 continue antibiotics. Latest BP-128-84. 4/9/2022-New onset AFib with flutter-Cardizem BID ordered, continue Toprol and start Eliquis. Eco-EF55-60% otherwise unremarkable.  4/10/2022-Tele NSR 70-80's 4/11/2022-Continue doxy & ceftriaxone on RA.  4/17/2022-HR-40-50's MD aware, map>65, spo2 90's RA.  4/18/2022- Rapid called, no responding to verbal stimuli, brady 4/18/2022- 52 and hypotensive 91/60. Bolus and atropine given improvement of HR to 85. Now on 2L 02 via NRB 02 sat was 86% now 100%. Placed on 2L NC. Finished ceftriaxone and doxy.  4/19/2022-Has intermittent delirium, with baseline HX of TBI/dementia. VSS.  4/20/2022-On RA now. 4/22/2022-VSS  97/65 HR 64  4/25/2022-BP-93/59 and HR 73. Spo2 97% on RA.  4/27/2022-Was awaiting local care placement received Covid -test.  4/28/2022- VSS, discharge to local care.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, SARS-CoV-2 test positive, Unresponsive to stimuli, White blood cell count normal
Clinical narrative: 4/6/2022-Presents to ED c/o AMS. Report of unwitnessed fall 2 days ago, no medical care. Covid + test. Ct head-no acute intracranial hemorrhage. Ct chest-mild bibasilar atelectasis. Admit AMS and PNA. B/P 170-190/100's. Started ceftriaxone and doxy. O2 sat 90's on RA. WBC's WNL.  4/7/2022-EEG -general slowing and no epileptiform discharges. Temp-100.1 continue antibiotics. Latest BP-128-84. 4/9/2022-New onset AFib with flutter-Cardizem BID ordered, continue Toprol and start Eliquis. Eco-EF55-60% otherwise unremarkable.  4/10/2022-Tele NSR 70-80's 4/11/2022-Continue doxy & ceftriaxone on RA.  4/17/2022-HR-40-50's MD aware, map>65, spo2 90's RA.  4/18/2022- Rapid called, no responding to verbal stimuli, brady 4/18/2022- 52 and hypotensive 91/60. Bolus and atropine given improvement of HR to 85. Now on 2L 02 via NRB 02 sat was 86% now 100%. Placed on 2L NC. Finished ceftriaxone and doxy.  4/19/2022-Has intermittent delirium, with baseline HX of TBI/dementia. VSS.  4/20/2022-On RA now. 4/22/2022-VSS  97/65 HR 64  4/25/2022-BP-93/59 and HR 73. Spo2 97% on RA.  4/27/2022-Was awaiting local care placement received Covid -test.  4/28/2022- VSS, discharge to local care.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram head normal, Condition aggravated, Fibrin D dimer
Clinical narrative: 4/29/2022-Presents to ED via EMS d/t AMS. HX of seizures,  not currently on any seizure meds. Covid +.  Ct head: no acute intracranial abnormality.  CXR- no acute cardiopulmonary disease. Admit MS exacerbation.  AMS back to baseline. D-Dimer 440. Started remdesivir and solumedrol (MS). VSS 96% on RA. 5/1/2022-Improving, maintaining o2 on RA. AMS returned to baseline.  5/3/2022- Recieved last dose of remdesivir. VSS Discharged to home.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental status changes, Multiple sclerosis, SARS-CoV-2 test positive
Clinical narrative: 4/29/2022-Presents to ED via EMS d/t AMS. HX of seizures,  not currently on any seizure meds. Covid +.  Ct head: no acute intracranial abnormality.  CXR- no acute cardiopulmonary disease. Admit MS exacerbation.  AMS back to baseline. D-Dimer 440. Started remdesivir and solumedrol (MS). VSS 96% on RA. 5/1/2022-Improving, maintaining o2 on RA. AMS returned to baseline.  5/3/2022- Recieved last dose of remdesivir. VSS Discharged to home.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Pallor, Syncope
Clinical narrative: Patient had a syncopal episode after receiving vaccine. Patient reported feeling dizzy and weak and appeared slightly pallid. She was given an ice pack, water, and a popsicle. Patient had not eaten or had anything to drink for several hours prior to vaccination. Blood pressure, pulse, and respirations were all within normal limits. Patient was alert and oriented x4. Symptoms resolved within 25 minutes. Patient continued in observation for an additional 15 minutes and then left was able to walk out with her mom.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody positive, Arthralgia, Myalgia, Red blood cell sedimentation rate increased
Clinical narrative: Elevated Sedimentation Rate - repeated blood work, symptoms: pain in joints and muscles Positive ANA
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal disorder
Clinical narrative: Patient experienced gastrointestinal symptoms that started approximately one week after Covid vaccine administration.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia, COVID-19, Chronic kidney disease, Cirrhosis alcoholic
Clinical narrative: The patient was admitted to a HCF on 02/24/2022 with end-stage alcoholic cirrhosis, hepatic encephalopathy, AKI on CKD, severe thrombocytopenia, acute anemia, and acute on chronic subdural hematoma.  The patient tested positive for COVID 19 on 2/24/22.  During the hospital course the patient intermittently required vasopressor support, and blood products, and was found not to be a candidate for dialysis.  The patient decided to proceed with DNR code status.  On 3/20/2022 he quickly decompensated, had AMS, and a CT head revealed small areas of subarachnoid hemorrhage.  The family wished to proceed with comfort measures.  The patient expired on 3/20/2022.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Death, General physical health deterioration, Hepatic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: The patient was admitted to a HCF on 02/24/2022 with end-stage alcoholic cirrhosis, hepatic encephalopathy, AKI on CKD, severe thrombocytopenia, acute anemia, and acute on chronic subdural hematoma.  The patient tested positive for COVID 19 on 2/24/22.  During the hospital course the patient intermittently required vasopressor support, and blood products, and was found not to be a candidate for dialysis.  The patient decided to proceed with DNR code status.  On 3/20/2022 he quickly decompensated, had AMS, and a CT head revealed small areas of subarachnoid hemorrhage.  The family wished to proceed with comfort measures.  The patient expired on 3/20/2022.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Subarachnoid haemorrhage, Subdural haematoma, Thrombocytopenia, Transfusion
Clinical narrative: The patient was admitted to a HCF on 02/24/2022 with end-stage alcoholic cirrhosis, hepatic encephalopathy, AKI on CKD, severe thrombocytopenia, acute anemia, and acute on chronic subdural hematoma.  The patient tested positive for COVID 19 on 2/24/22.  During the hospital course the patient intermittently required vasopressor support, and blood products, and was found not to be a candidate for dialysis.  The patient decided to proceed with DNR code status.  On 3/20/2022 he quickly decompensated, had AMS, and a CT head revealed small areas of subarachnoid hemorrhage.  The family wished to proceed with comfort measures.  The patient expired on 3/20/2022.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Shortly following vaccination I developed tinnitus that has not stopped since.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 57.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Complaints of itching at site ( left inner forearm) since 8/26/2022. Not improved after using hydrocortisone cream.  Area of redness is the size of the dime and has not increased since vaccine given.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Clostridium test positive, Death, Endotracheal intubation
Clinical narrative: The patient had a PMH of severe COPD s/p R lung transplant (2016), CKD 4, BK virus nephropathy, Stage III melanoma with Lymph node metastasis presented to a local ED following a ground-level fall on 2/17/2022 with left-sided weakness.  MRI did not show any clear evidence of an acute infarct.  Found to have C3-4 disc herniation with pre-existing spinal canal stenosis, s/p ACDF with neurosurgery on 2/25/22.  On 3/2/2022 the patient was found to have Covid-19 and treated with Dexamethasone and Remdesivir.  The patient then tested positive for C. diff 3/7/2022 and received PO vanc.  On 3/11/22 the patient became acutely hypoxic and was transferred to MICU and initiation on therapeutic anticoagulation for suspicion of PE.  The patient required intubation.  On 3/13 CRRT was initiated and had 2 L taken off with improvement in his oxygenation.  The patient continued to decline and was made DNR/DNI and expired on 3/17/2022.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, General physical health deterioration, Haemofiltration, Hemiparesis, Hypoxia
Clinical narrative: The patient had a PMH of severe COPD s/p R lung transplant (2016), CKD 4, BK virus nephropathy, Stage III melanoma with Lymph node metastasis presented to a local ED following a ground-level fall on 2/17/2022 with left-sided weakness.  MRI did not show any clear evidence of an acute infarct.  Found to have C3-4 disc herniation with pre-existing spinal canal stenosis, s/p ACDF with neurosurgery on 2/25/22.  On 3/2/2022 the patient was found to have Covid-19 and treated with Dexamethasone and Remdesivir.  The patient then tested positive for C. diff 3/7/2022 and received PO vanc.  On 3/11/22 the patient became acutely hypoxic and was transferred to MICU and initiation on therapeutic anticoagulation for suspicion of PE.  The patient required intubation.  On 3/13 CRRT was initiated and had 2 L taken off with improvement in his oxygenation.  The patient continued to decline and was made DNR/DNI and expired on 3/17/2022.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Intervertebral disc operation, Intervertebral disc protrusion, Magnetic resonance imaging normal, Pulmonary embolism
Clinical narrative: The patient had a PMH of severe COPD s/p R lung transplant (2016), CKD 4, BK virus nephropathy, Stage III melanoma with Lymph node metastasis presented to a local ED following a ground-level fall on 2/17/2022 with left-sided weakness.  MRI did not show any clear evidence of an acute infarct.  Found to have C3-4 disc herniation with pre-existing spinal canal stenosis, s/p ACDF with neurosurgery on 2/25/22.  On 3/2/2022 the patient was found to have Covid-19 and treated with Dexamethasone and Remdesivir.  The patient then tested positive for C. diff 3/7/2022 and received PO vanc.  On 3/11/22 the patient became acutely hypoxic and was transferred to MICU and initiation on therapeutic anticoagulation for suspicion of PE.  The patient required intubation.  On 3/13 CRRT was initiated and had 2 L taken off with improvement in his oxygenation.  The patient continued to decline and was made DNR/DNI and expired on 3/17/2022.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Spinal stenosis
Clinical narrative: The patient had a PMH of severe COPD s/p R lung transplant (2016), CKD 4, BK virus nephropathy, Stage III melanoma with Lymph node metastasis presented to a local ED following a ground-level fall on 2/17/2022 with left-sided weakness.  MRI did not show any clear evidence of an acute infarct.  Found to have C3-4 disc herniation with pre-existing spinal canal stenosis, s/p ACDF with neurosurgery on 2/25/22.  On 3/2/2022 the patient was found to have Covid-19 and treated with Dexamethasone and Remdesivir.  The patient then tested positive for C. diff 3/7/2022 and received PO vanc.  On 3/11/22 the patient became acutely hypoxic and was transferred to MICU and initiation on therapeutic anticoagulation for suspicion of PE.  The patient required intubation.  On 3/13 CRRT was initiated and had 2 L taken off with improvement in his oxygenation.  The patient continued to decline and was made DNR/DNI and expired on 3/17/2022.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error, Wrong product administered
Clinical narrative: Pt was given diluent for Pfizer vaccine 5-11yr. Diluent was not mixed with vaccine.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Facial paralysis, Hemiplegia
Clinical narrative: About a month following the second COVID vaccine shot on 4/17/21, the paralysis on the left side of my face started, about 5/17/21. I was concerned and went to the Urgent Care af few days later and they persciribed me coricosteriods and an antiviral. I informed them that I received a COVID vaccine shot a month previous but there was no response to that concern of mine. They asked if I recently had shingles or stress related life events. I informed them that I had shingles about a year previous and that I just started a new job.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Haemorrhage, Scratch
Clinical narrative: Was administering vaccine while patient was sitting in the lap of the MOC of care.  Both myself and the mother of care were holding on to  the child to stabilize the leg and properly administer the vaccine.  Both the grips of myself and the mother of care were not tight enough.  Patient slipped loose and the needle scratched the leg of the patient.  No reactions other than slight bleeding and scratch on leg.
Age: 1.33
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given .25ml of The booster 50mcg 0.5ml instead of the Moderna 6m-<5 dose 25mcg .25ml
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received a Moderna booster vaccine on 8/24/2022 and again on 8/31/2022.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Clinic consulted with Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Clinic is working with Public Health on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Gait inability, SARS-CoV-2 test positive
Clinical narrative: The patient was admitted to Health and Rehab from home with a history of generalized weakness, inability to walk and inability of his family to care for him.  The patient had a history of carcinoma of the prostate and was treated with antiandrogen drugs.  The patient was admitted for palliative care.  The patient tested positive for Covid 19 on 2/14/22.  The patient expired on 3/2/2022.
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient was given 2nd booster dose of covid moderna before the age of 50 and without any high risk concerns. No treatment at the time.
Age: 0.58
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient given 0.25mL of Moderna booster 50mcg instead of the Moderna 25mcg.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 61.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Pain, Skin discolouration, Swelling
Clinical narrative: swelling size of golfball-veins turning black, pain
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid, C-reactive protein, COVID-19, COVID-19 pneumonia, Computerised tomogram thorax abnormal
Clinical narrative: Hospitalization for COVID-19 infection after COVID-19 immunization. This 84-year-old female with a history of advanced medullary thyroid cancer presented to her medical oncologist with symptoms of cough and breathing difficulties associated with a positive home test for SARS-CoV-2. She was found to be hypoxemic requiring O2 supplementation at 2L/min with CT scan changes consistent with COVID-19 pneumonia. She was transferred to hospital and admitted. She is receiving treatment with dexamethasone, remdesivir and enoxaparin. She now is afebrile and shown improvement in symptom severity. The management coordinator is actively planning for comprehensive follow-up healthcare after discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Fibrin D dimer, Full blood count, Hypoxia
Clinical narrative: Hospitalization for COVID-19 infection after COVID-19 immunization. This 84-year-old female with a history of advanced medullary thyroid cancer presented to her medical oncologist with symptoms of cough and breathing difficulties associated with a positive home test for SARS-CoV-2. She was found to be hypoxemic requiring O2 supplementation at 2L/min with CT scan changes consistent with COVID-19 pneumonia. She was transferred to hospital and admitted. She is receiving treatment with dexamethasone, remdesivir and enoxaparin. She now is afebrile and shown improvement in symptom severity. The management coordinator is actively planning for comprehensive follow-up healthcare after discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Liver function test, Metabolic function test, SARS-CoV-2 test positive, Serum ferritin
Clinical narrative: Hospitalization for COVID-19 infection after COVID-19 immunization. This 84-year-old female with a history of advanced medullary thyroid cancer presented to her medical oncologist with symptoms of cough and breathing difficulties associated with a positive home test for SARS-CoV-2. She was found to be hypoxemic requiring O2 supplementation at 2L/min with CT scan changes consistent with COVID-19 pneumonia. She was transferred to hospital and admitted. She is receiving treatment with dexamethasone, remdesivir and enoxaparin. She now is afebrile and shown improvement in symptom severity. The management coordinator is actively planning for comprehensive follow-up healthcare after discharge.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given outside of recommended exp. date
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash macular
Clinical narrative: Facial rash about 10 minutes after receiving vaccine. No SOB, cough, abdominal pain or N/V/D. Rash was splotchy and erythematous (non-blanching).
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Tremor
Clinical narrative: Chills, shaking, exhaustion, headache
Age: 51.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Product administration error
Clinical narrative: No Wheal on first administration. 2nd administration was successful.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Intensive care, Pulmonary embolism, Thrombectomy
Clinical narrative: Sizeable bilateral pulmonary emboli and deep vein thrombosis Rt popliteal area discovered on July 12, 2022 .... no known preexisting conditions or family history of clots
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Vena cava filter insertion
Clinical narrative: Sizeable bilateral pulmonary emboli and deep vein thrombosis Rt popliteal area discovered on July 12, 2022 .... no known preexisting conditions or family history of clots
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest pain, SARS-CoV-2 test positive
Clinical narrative: Patient came to ED with chest pain.  Had tested positive for covid 8/3/22 and was admitted with covid pneumonia 8/14 and treated with remdesivir.
Age: 45.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Wrong technique in product usage process
Clinical narrative: No Wheal on first administration. 2nd administration was successful.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Arthralgia, Back pain, Blood test abnormal, Catheter placement, Chest discomfort
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Chest pain, Dehydration, Disorientation, Dizziness, Electrocardiogram normal
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Fatigue, Feeling hot, Headache, Immunisation reaction, Injection site erythema
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Injection site rash, Injection site swelling, Pain, Pharyngeal erythema, Rash
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: SARS-CoV-2 test negative, Streptococcus test negative, Swelling, Throat irritation, Urinary tract infection
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 36.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Urine analysis, White blood cell count increased
Clinical narrative: He got his 2nd vaccine, about 2 hours later he had a bump on the back of his neck and a small rash.  From the pamphlet he received said that was normal.  he started to feel tired as the day went on.  By the evening his arm was doubled in size around the injection site, he was hot, painful and his joints were starting to hurt.  It wasn't until later in the evening where he was looking over the notes of what was said about the vaccine and decided something was wrong.  He started to feel disoriented and scratchy throat.  He was so disoriented he could not remember where his EPI pen was as he is allergic to bees (anaphylactic).  He called a friend to pick him up, they had stopped to get Benadryl and he called 9-1-1.  He first talked to a dispatcher and they sent him to the fire department who transferred him to poison control was on hold and contacted the hospital and about an hour he was admitted into the ER, which is down the road from where he lives, and treated for the allergic reaction.   The states knowledge about this vaccine was very limited and they bounced him around to get some assistance.  They thought he had monkey pox and not a reaction to vaccine.   He was given 60 mg of Prednisone, even though he had taken 25 mg of Benadryl and gave him 50 mg of Benadryl and some Famotidine.  They did an EKG that was normal, COVID test was negative, strep test was negative as his throat was red.  The redness started to go down around the injection site and then released about 3:00-4:00 AM on Friday morning.    They sent him home to be on 60 mg of Prednisone and the Benadryl as needed, to take every 4 hours as needed.  From Friday to Sunday morning he woke up with different symptpoms of rash on his feet, rash at the injection site ,and was taking the Prednisone.  Sunday morning he woke up with headache, didn't have the rash on his feet, but did have a large rash around the injection site.  he also was feeling the joint pain again and went back to the ER with low back pain, tightness in his chest, chest pain, light headed and headache.  During that time they admitted him to the ER, they ran a full 12 lead EKG, they did a lot of different blood tests, urinalysis, blood test from his heart.  Blood work showed some dehydration, extremely high WBC in which they did administer fluids, put in a catheter.  He was pretty anxious so they gave him Ativan and with the lower back pain they gave him a non-noncardiac anti-inflammatory and diagnosed with a UTI secondary to the allergic reaction to the vaccine.   He was given a large dose of Cephalosporin, finished the prednisone yesterday and is taking an allergy pill in the morning Loratadine, and takes 1500 mg a day of Keflex.    His first vaccine was given IM in the back of his arm and he did not have any reaction to that.    He is a transgender female/male with transformation 13 years ago, and is on Testosterone injections weekly.
Age: 93.0
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Asymptomatic, CP
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Seizure
Clinical narrative: Patient has had seizures since 2009. Admitted to Epilelpsy Monitoring Unit for seizure characterization.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Patient presented to clinic 8/10/2022 for Moderna booster dose. Patient was given 0.25 mL of Moderna red cap vial in left deltoid, dose verified. On 8/31/2022 it was identified that patient did not qualify for booster dose as she had already received one and was not in the correct age category for second booster. Nurse manager was notified immediately. Patient was called 8/31/2022 and notified of the incident. Patient states "works in healthcare and was due for booster". Notified of CDC guidelines. Patient verbalized understanding and states "did not have any reaction felt fine and just had a sore arm after injection". QIR also submitted.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.